
DH holds World AIDS Campaign 2024 Kick-off Ceremony to promote prevention of HIV infection and inaugural HIV Testing Month
The Department of Health (DH) and Hong Kong Advisory Council on AIDS (ACA) today (November 30) jointly held the World AIDS Campaign 2024 Kick-off Ceremony to raise public awareness of the prevention of Human Immunodeficiency Virus (HIV) infection. The DH also announced the launch of the inaugural HIV Testing Month in Hong Kong, encouraging people who have had sex to undergo HIV testing at least once to keep track of their own health status. People with HIV should seek specialist care and HIV treatment as soon as possible for viral suppression and for health restoration. The World Health Organization (WHO) has designated December 1 (i.e. tomorrow) each year as World AIDS Day, and today's event was organised in response to this observance. Under the theme "Advances with Love, 40 Years of United Actions & Beyond", the ceremony reflected on the past and future joint efforts between the Government, healthcare sector and non-governmental organisations (NGOs) to combat AIDS and care for patients and their families through a multipronged approach and strategic collaboration since the first case of HIV infection was reported in Hong Kong in 1984. Officiating at the ceremony, the Director of Health, Dr Ronald Lam, said, "The prevalence of HIV infection in Hong Kong remains well below the global average, accounting for 1 in 1 000 of the adult population. The number of new cases in recent years has continued to drop from the peak in 2015, which is encouraging. However, we must not be complacent, as the proportion of late presenters in Hong Kong has been on the rise in recent years, and the number of newly infected persons aged 50 or above has not dropped in tandem with the overall number of newly infected persons. Furthermore, various challenges such as stigma and discrimination still exist." In view of this, the Red Ribbon Centre of the DH, in collaboration with 12 NGOs and 10 supporting organisations, is launching the inaugural HIV Testing Month in Hong Kong in December (i.e. from tomorrow onwards), with a view to increasing the public's awareness of HIV testing in Hong Kong, as well as helping the public understand how to get tested for HIV easily and conveniently through a variety of channels. The Scientific Committee on AIDS and STI has earlier issued its recommendation that people who have had sex should get HIV testing at least once. Dr Lam said, "The launch of HIV Testing Month aims to promote the normalisation of HIV testing. Members of the public can browse the HIV Testing Service website (www.hivtest.gov.hk) or access the HIV testing calendar on the HIV Testing Service website via the '@DH mobile application' to learn more about and select testing resources in the community." The Government will launch a new Announcement of Public Interest (API) under the slogan "For your health, get tested for HIV" to appeal to people who have had sex to get tested for HIV at least once, so that those who are unaware of their infection status can receive timely diagnosis and treatment. Normalising HIV testing will also help remove the negative stigma associated with HIV infection and testing. The ceremony was attended by around 100 stakeholders who have been involved in the fight against AIDS since the 1980s.
More Information
2024.11.30

Endowed Professorships ceremony
An Endowed Professorship is one of the most significant awards bestowed upon eminent academics within the University in support of their academic and research activities.Prof Chen is awarded Suen Chi-Sun Professorship in Clinical Science at October 2024.
More Information
2024.11.25

Clarivate Highly Cited Researchers 2024 and other ranking systems
Clarivate has named a record-breaking 32 researchers from HKUMed as ‘Highly Cited Researchers 2024’ today (19 November 2024). This accolade further affirms our steadfast commitment to innovation and excellence in medical and health research. Hong Kong has proudly secured its position as the 8th highest-ranking region globally, with 134 researchers recognised as Highly Cited Researchers (HCRs). Among them, 55 are HKU scholars, and HKUMed accounts for 58.2% of the HKU total (32 out of 55) and 23.9% of the Hong Kong total (32 out of 134), respectively. This research accolades highlighted HKUMed’s significant role in contributing to the city’s ascent into the global Top 10 and is yet another example of our global academic excellence and research prowess. Record number of HKUMed scientists named Highly Cited Researchers 2024 by Clarivate In economics, GDP per capita is an important indicator of economic prosperity. In the context of research impact, the number of HCRs per capita provides a likewise metric for global scientific and technological progress. In this regard, Hong Kong leads the world with the highest number of HCRs per capita, boasting an impressive 18.4 HCRs per one million population. As a major driver to this success, HKUMed ranked 8th globally, surpassing major countries / regions like Germany and France.[i] This underscores the extraordinary concentration of top researchers and eminent scientists among us in the Medical Faculty. I extend my heartfelt commendation to our scholars and researchers for their unwavering dedication and hard work! At the same time, members may have observed a proliferation of university rankings, with each ranking system emphasising different criteria and catering to diverse perspectives and purposes. For instance, the Global Ranking of Academic Subjects (GRAS) released most recently by Shanghai Ranking evaluates universities worldwide by subjects using a unique methodology. The six subjects applicable to HKUMed included Human Biological Sciences, Clinical Medicine, Public Health, Nursing, Pharmacy & Pharmaceutical Sciences and Medical Technology. Interestingly, HKUMed ranks 15th in the Public Health subject and >100 in Clinical Medicine. This stands in stark contrast with some university ranking systems which use more comprehensive metrics such as Times Higher Education (Clinical & Health) and QS World University Rankings (Life Sciences & Medicine), which respectively ranked HKUMed as 19th and 31st in the world in 2024 and consistently amongst the top medical schools worldwide years after years. It is therefore crucial to interpret such multi-faceted ranking results with a discerning eye. I will provide more details on the relevant rankings at the upcoming Dean & Heads Advisory Committee and Faculty Board meetings. HKUMed’s recent achievements, including our leadership roles in The Hong Kong Jockey Club Global Health Institute and the Greater Bay Area International Clinical Trial Institute, as well as our membership in the World Health Summit Academic Alliance, have strategically positioned us to tackle new and emerging challenges. These successes not only advance Hong Kong’s health agenda but also allow us to make a substantial impact on global health.
2024.11.19

UNAIDS Visit Hong Kong AIDS Foundation
Dr. Erasmus Morah and his delegation from UNAIDS, China on last Friday (15th November 2024). Organized on short notice, this visit was a testament to the agility and efficiency of our team and provided a significant platform to align with global health initiatives.
Overview and Background
The primary purpose of this Courtesy Call was to discuss two new Memorandums of Understanding (MoUs) signed with China in 2024, marking a pivotal step in our collaborative efforts. This meeting underscored our strategic positioning and commitment in the global fight against HIV/AIDS, highlighting the vital role we play in these international partnerships.
Luncheon Discussion
The discussions began with a luncheon hosted by Dr. Leong and attended by our esteemed Board Member Prof. Chen Zhiwei. During this session, Dr. Morah presented the new MOUs and outlined UNAIDS's strategic plans moving forward. We took this opportunity to share our Fundation’s mission and vision, showcasing how our objectives support and enhance the goals set forth in the MOUs. The dialogue was both engaging and enlightening, setting a collaborative tone for the remainder of the visit.
Visit of the Shau Kei Wan Headquarters
Following the luncheon, Dr. Wilson Lam led a detailed visit of our Shau Kei Wan headquarters. He led our team to present an overview of the Foundation's operations, emphasizing our efforts to expand global and national partnerships. Dr. Lam highlighted specific projects and initiatives that demonstrate our Foundation's significant impact within the community and our extensive network collaborations, especially with Mainland China.
Key Highlights
Volunteer Leadership Sharing Session: A highlight of the visit was the session where Dr. Morah met with our volunteer leaders. This meeting was not only a forum for our volunteers to showcase their passion and commitment but also allowed them to receive strategic guidance from Dr. Morah. The exchange provided valuable insights into enhancing our advocacy and outreach efforts, which are crucial for our ongoing success.
Patient Group Activity: Dr. Morah also took part in an engaging activity with our PLHIV members, where they created traditional artwork from red pocket envelopes. This session provided Dr. Morah with a direct opportunity to connect with our members and understand their overall situations and specific needs. It also showcased how the "95-95-95" UNAIDS targets could potentially be implemented within Hong Kong. The activity emphasized our innovative approach to integrating cultural heritage into our support programmes, which left a lasting impression on the delegation.
Presentation of Souvenirs and Group Photos
The visit concluded with the presentation of handmade souvenirs, crafted from red pocket envelopes, symbolizing eternal friendship and well-wishes for health and prosperity. We captured these moments of shared commitment with a group photo, creating lasting memories of our collaboration.
Feedback from UNAIDS
The feedback from the UNAIDS delegation was exceptionally positive. Dr. Morah expressed gratitude for our thorough organization and the depth of interactions during the visit. Their appreciation was further highlighted in a post on their official social media platform, X. This recognition can be viewed here: UNAIDS Post on X
Acknowledgments
Our thanks go to Dr. Leong for his guidance during the visit, to Prof. Chen Zhiwei for his invaluable contributions at the luncheon, and to Dr. Wilson Lam for his exemplary leadership and flexibility in adjusting his work schedule. Their efforts were crucial to the success of this important event.
Conclusion
This visit has not only reinforced our international relationships but has also invigorated our team, affirming our Foundational role in the global health landscape. We eagerly anticipate building on this momentum to further our mission.
2024.11.20

Clarivate Highly Cited Researchers 2024 and other ranking systems
Statistics at a glance:
2024 Highly Cited Researchers – Hong Kong: 134; HKU: 55; HKUMed: 32.
2024 THE World University Rankings – 19th worldwide in ‘Clinical and Health’.
2024 QS World University Rankings - 31st globally in ‘Life Sciences and Medicine’.
Clarivate has named a record-breaking 32 researchers from HKUMed as ‘Highly Cited Researchers 2024’ today (19 November 2024). This accolade further affirms our steadfast commitment to innovation and excellence in medical and health research.
Hong Kong has proudly secured its position as the 8th highest-ranking region globally, with 134 researchers recognised as Highly Cited Researchers (HCRs). Among them, 55 are HKU scholars, and HKUMed accounts for 58.2% of the HKU total (32 out of 55) and 23.9% of the Hong Kong total (32 out of 134), respectively. This research accolades highlighted HKUMed’s significant role in contributing to the city’s ascent into the global Top 10 and is yet another example of our global academic excellence and research prowess.
In economics, GDP per capita is an important indicator of economic prosperity. In the context of research impact, the number of HCRs per capita provides a likewise metric for global scientific and technological progress. In this regard, Hong Kong leads the world with the highest number of HCRs per capita, boasting an impressive 18.4 HCRs per one million population. As a major driver to this success, HKUMed ranked 8th globally, surpassing major countries / regions like Germany and France.[i] This underscores the extraordinary concentration of top researchers and eminent scientists among us in the Medical Faculty. I extend my heartfelt commendation to our scholars and researchers for their unwavering dedication and hard work!
2024.11.19

Seminar: Engineering Next-Generation of Viral Vectors for Gene Therapy
2024.03.15

艾沐茵結合傳統治療 有望成對抗愛滋病有效療法
專訪|艾沐茵結合傳統治療 有望成對抗愛滋病有效療法
2023.12.28

五十一位學者獲嘉許 港大「2023年度最廣獲徵引研究人員」排名全球13位
新聞連結
科睿唯安(Clarivate) 最新公佈「2023年度最廣獲徵引研究人員」,香港大學(港大)有55學者人次(即計入在多於一個學術領域獲獎的學者)入選,在全球眾院校和科研機構中高踞第13位。
港大今年有51位(數目經Clarivate修訂)傑出學者晉身「2023年度最廣獲徵引研究人員」,創歷年新高。科睿唯安的分析指,由於港大2023年在全球學術同儕中的排名顯著上升,讓香港因而躋身十大地區和國家排名之列。
根據科睿唯安分析,全球有來自67個國家和地區的6,849名學者獲「2023年度最廣獲徵引研究人員」。計入在多於一個學術領域獲獎的學者,今年獲獎人次達7,125,其中3,793位屬於專門的學術範疇,3,332位於跨領域研究發揮影響力。他們的學術著作獲國際間同儕學者廣泛徵引,在學術界中極具影響力。
今年港大的入選學者數目持續增加,人數繼續是香港院校中最多。獲選錄的都是學術表現卓越的世界頂級學者,他們的多份學術著作,2012至2022年間在其學術範疇得以晉身全球被引用最多首1%的學術文章,是所屬研究領域内極具影響力的人物。
「2023年度最廣獲徵引研究人員」名錄中的51位港大學者包括(按英文姓氏排列):
化學戴宏杰教授理學院化學系講座教授
Fraser Stoddart理學院化學系講座教授
化學,材料科學譚超良博士工程學院電機電子工程系助理教授
計算機科學黃凱斌教授工程學院電機電子工程系教授及副系主任
跨領域施綺芸教授李嘉誠醫學院公共衞生學院名譽教授
陳雲玫博士李嘉誠醫學院臨床醫學學院微生物學系專職研究員陳鴻霖教授李嘉誠醫學院臨床醫學學院微生物學系教授
陳志偉教授李嘉誠醫學院臨床醫學學院微生物學系免疫學和免疫療法學講座教授、香港大學愛滋病研究所所長鄭智聰教授李嘉誠醫學院臨床醫學學院微生物學系名譽臨床教授
郭健恒博士李嘉誠醫學院臨床醫學學院微生物學系副教授黎青龍教授李嘉誠醫學院榮休教授林讚育教授李嘉誠醫學院公共衞生學院副教授
劉浩然博士李嘉誠醫學院公共衞生學院名譽助理教授李玉國教授工程學院機械工程系建築環境講座教授梁順林教授社會科學學院地理系講座教授
梁詩敏博士李嘉誠醫學院公共衞生學院流行病和生物統計學助理教授麥德華教授李嘉誠醫學院臨床醫學學院病理學系名譽教授裴偉士教授李嘉誠醫學院公共衞生學院病毒學講座教授、譚華正基金教授(醫療科學)譚永輝醫生李嘉誠醫學院臨床醫學學院內教學系名譽臨床助理教授
湯初陽教授工程學院土木工程系講座教授
汪涵教授工程學院電機電子工程系教授王中銳博士工程學院電機電子工程系助理教授
胡子祺教授李嘉誠醫學院公共衞生學院流行病和生物統計學教授吳蓬博士李嘉誠醫學院公共衞生學院流行病和生物統計學助理教授嚴慧玲博士李嘉誠醫學院公共衞生學院公共衞生實驗室科學副教授
楊偉國教授李嘉誠醫學院臨床醫學學院矯形及創傷外科學系教授
尹曉波教授港大協理副校長、工程學院及理學院教授葉植恩博士李嘉誠醫學院臨床醫學學院微生物學系名譽助理教授張錦霞博士李嘉誠醫學院臨床醫學學院微生物學系科學主任
張曉玲教授建築學院房地產及建設系教授
周婕博士李嘉誠醫學院臨床醫學學院微生物學系助理教授
周宇宇教授社會科學學院地理系教授
環境及生態;地球科學劉竹教授社會科學學院地理系教授
地球科學宮鵬教授港大副校長(學術發展)、社會科學學院及理學院講座教授趙國春教授理學院地球科學系講座教授
免疫學蔡建飄先生李嘉誠醫學院臨床醫學學院微生物學系專職研究員孔繁毅教授李嘉誠醫學院臨床醫學學院內科學系傳染病科講座教授、列汝儉列黃瑞容基金教授(健康科學教育學), 及傳染病科主任
梁卓偉教授李嘉誠醫學院公共衞生學院名譽臨床教授
免疫學,微生物學陳福和醫生李嘉誠醫學院臨床醫學學院微生物學系臨床副教授陳國雄博士李嘉誠醫學院臨床醫學學院微生物學系名譽助理教授
朱軒博士李嘉誠醫學院臨床醫學學院微生物學系助理教授杜啟泓教授李嘉誠醫學院臨床醫學學院微生物學系系主任兼臨床教授袁國勇教授李嘉誠醫學院臨床醫學學院微生物學系傳染病學講座教授、霍英東基金教授(傳染病學)
免疫學,社會科學高本恩教授李嘉誠醫學院公共衞生學院流行病和生物統計學分部主任、流行病學講座教授
材料科學李連忠教授工程學院機械工程系未來電子講座教授
微生物學潘烈文教授李嘉誠醫學院公共衞生學院公共衞生實驗室科學分部主任、公共衞生病毒學講座教授
袁碩峰博士李嘉誠醫學院臨床醫學學院微生物學系助理教授張彤教授工程學院土木工程系環境工程講座教授
物理學姚望教授理學院物理學系講座教授張霜教授理學院及物理學系系主任(暫任)、講座教授、工程學院電機電子工程系講座教授張翔教授港大校長、工程學院及理學院講座教授傳媒查詢香港大學傳訊及公共事務處尹慧筠 電話:2859 2600 | 電郵:melwkwan@hku.hk吳婷 電話:3910 3612| 電郵: ngjaymee@hku.hk蔡建豪 電話:2859 2607|電郵: khkchoi@hku.hk
2023.11.15

【紫荊專稿】何大一、袁國勇、陳志偉:推動公共衞生領域的國際合作
新聞連結
2023.07.27